PHARMACCINES FOR LIFE
Dead · Refused DEAD/APPLICATION/Refused/Dismissed or InvalidatedWhat this record means
The record shows that “PHARMACCINES FOR LIFE” is an abandoned application – the USPTO marked it dead on June 25 2003 after the owner, Pharmexa A/S, failed to file a required Statement of Use or an extension after the Notice of Allowance was issued. The filing covered Class 001 chemical products used to develop pharmaceuticals and vaccines, Class 005 pharmaceutical preparations for a wide range of disorders and various vaccine types, and Class 042 scientific and biomedical research services related to vaccines and drug testing. Because the goods and services are tightly focused on biotech‑pharmaceutical development, a similar name used in those same areas would present the closest record‑based concern, while uses outside those fields are farther from the scope shown. The record does not give the owner control over every possible use of the words “pharmaccines” or “for life.” The latest meaningful event is the abandonment entry on September 15 2003, and no opposition, cancellation or court activity appears in the history. I'd treat this as a meaningful concern if you plan a name in the vaccine or pharmaceutical research space.
Informational only - not legal advice.Mark Trademark, Service Mark
| Drawing type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
| Filing basis | Intent-to-Use (§1(b)). |
| Status | Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | Oct 29, 2001 |
| Published for opposition | Oct 01, 2002 |
| Notice of Allowance | Dec 24, 2002 |
| Status date | Jun 25, 2003 |
Goods & services
Chemical products for use in the development of pharmaceuticals, vaccines, namely therapeutic, subcomponent, polypeptide and live vaccines, viral and nucleic acids vaccines, DNA vaccines, vaccine excipients, vaccine carriers, and vaccine adjuvants for medical science; chemical preparations for analyses in laboratories for in vivo analyses for medical purposes; non-pathogenic microorganisms and vira for vaccine use, polypeptides, protein and nucleic acids, including DNA for vaccine use
Pharmaceutical preparations and substances for the treatment of neoplastic disorders, inflammatory disorders, infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; vaccines, namely, therapeutic vaccines, subcomponent vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleic acid vaccines and DNA vaccines, vaccine excipients, vaccine carriers, vaccines adjuvants; vaccines containing non-pathogenic microorganisms and vira; vaccines containing polypeptides, protein and nucleic acids, including DNA; 00
Scientific, industrial biotechnological and biomedical research; pharmaceutical, biomedical and biotechnological development of therapeutic vaccines, other vaccines and pharmaceuticals; chemical, biochemical and molecular biological analyses; medical and scientific research, namely in vitro and in vivo preclinical tests of potential drugs; medical and scientific research, namely in vitro and in vivo research concerning therapeutic vaccines, other vaccines and potential drugs; scientific, industrial biotechnological and biomedical consultancy concerning the above analyses, tests and research; biomedical and pharmaceutical clinical testing and research
Owner & representation
| Owner | Pharmexa A/S |
| Address | Kogle Allé 6, 2970 Horsholm DENMARK |
| Entity | PUBLIC LIMITED COMPANY - organized in DENMARK |
| Attorney of record | Cynthia Clarke Weber |
| Correspondent | CYNTHIA CLARKE WEBER |
| Attorney email | c********@*****.com |
| Correspondent email | c********@*****.com |
| Correspondent phone | 2********7 |
| Correspondent address | WASHINGTON, DISTRICT |